STAT+: The FDA’s diagnostics chief, who led through Covid, has retired
STAT
JANUARY 18, 2024
The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. It was a hectic time.
Let's personalize your content